Repository logo
 
Publication

ARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugal

2021-02-01Journal article Open access
Simple item page
dc.contributor.authorFonseca, J
dc.contributor.authorTaveira-Gomes, T
dc.contributor.authorPereira, AM
dc.contributor.authorBranco-Ferreira, M
dc.contributor.authorCarreiro-Martins, P
dc.contributor.authorAlves-Correia, M
dc.contributor.authorCorreia de Sousa, J
dc.contributor.authorCosta, E
dc.contributor.authorLourenço, O
dc.contributor.authorMorais-Almeida, M
dc.contributor.authorMorête, A
dc.contributor.authorRegateiro, F
dc.contributor.authorTodo Bom, A
dc.contributor.authorBachert, C
dc.contributor.authorPfaar, O
dc.contributor.authorWallace, D
dc.contributor.authorBedbrook, A
dc.contributor.authorCzarlewski, W
dc.contributor.authorBousquet, J
dc.date.accessioned2021-03-22T16:24:11Z
dc.date.available2021-03-22T16:24:11Z
dc.date.issued2021-02-01
dc.description.abstractThe Allergic Rhinitis and Its Impact on Asthma (ARIA) initiative started more than 20 years ago and has developed and disseminated evidence-based guidelines and projects in the field of allergic rhinitis. This initiative is currently focused on providing patient-centred guidelines that contribute to an integrated care pathway between the various levels of care and take advantage of digital solutions, and the introduction of integrated care pathways in clinical practice has been recommended. In this article we describe the adaptation for Portugal of the ARIA Integrated Care Pathways document. After a brief review of the epidemiology and impact of allergic rhinitis in Portugal and the activities carried out in Portugal within the ARIA initiative, we describe the broad knowledge base used for the development of recommendations for the pharmacological treatment of allergic rhinitis, and these recommendations are based on the GRADE methodology, real world evidence acquired by mobile technology (mHealth) and resulting from allergenic exposure chamber studies. What follows is a summary of integrated care pathways for allergen immunotherapy produced in 2019. Allergen immunotherapy is considered an example of precision medicine where the use of mHealth technologies will improve stratification for patient selection and response monitoring. These recommendations were considered as best practices of integrated patient-centred care supported by digital systems from Directorate General for Health and Food Safety of the European Union (DG Santé) and represent the ARIA Phase 4 Change Management strategy.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Med Port . 2021 Feb 1;34(2):144-157pt_PT
dc.identifier.doi10.20344/amp.13777pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3623
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.publisherCentro Editor Livreiro da Ordem dos Médicospt_PT
dc.subjectAsthmapt_PT
dc.subjectClinical Practice Guidelinept_PT
dc.subjectDelivery of Health Carept_PT
dc.subjectRhinitis, Allergic.pt_PT
dc.subjectPortugalpt_PT
dc.subjectHDE ALERpt_PT
dc.titleARIA 2019: An Integrated Care Pathway for Allergic Rhinitis in Portugalpt_PT
dc.title.alternativeARIA 2019: Um Percurso Assistencial Integrado para a Rinite Alérgica em Portugalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage157pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage144pt_PT
oaire.citation.titleActa medica portuguesapt_PT
oaire.citation.volume34pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Acta Med Port 2021_34_144.pdf
Size:
856.83 KB
Format:
Adobe Portable Document Format
Download

Collections

ALER - Artigos